跳至主要内容
临床试验/EUCTR2008-004820-22-GB
EUCTR2008-004820-22-GB进行中(未招募)1 期

Alcohol detoxification in primary care treatment (ADEPT) - a feasibility study of conducting a randomised trial in primary care comparing two pharmacological regimens. - Alcohol detoxification in primary care treatment (ADEPT)

niversity of Bristol0 个研究点目标入组 60 人开始时间: 2010年11月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Inclusion criteria. Anyone (18-65 years old) consulting their GP for whom a community based alcohol detox requiring medication is appropriate. Due to acamprosate’s license for maintaining abstinence, nobody under age of 18 and over 65 will be recruited.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria. Since patients will be selected after their GP has made the decision to offer home/community detox it follows that they will not fulfill criteria for admission or more specialist monitoring: current or significant history of delirium tremens or seizures, current or history of high dose polydrug use, significant medical or psychiatric ill health, pregnant or breast feeding or Wernicke’s encephalopathy. The absence of these factors make it unlikely that any patient will not be able to take acamprosate since its contraindications are renal and severe hepatic impairment; in addition to pregnancy and breast-feeding.

研究者

发起方
niversity of Bristol

相似试验